Perrigo is a global healthcare company that specializes in the development, manufacturing, and distribution of over-the-counter (OTC) consumer products and pharmaceuticals
The company focuses on delivering affordable healthcare solutions, including dietary supplements, allergy medications, and personal care products. With a strong emphasis on quality and innovation, Perrigo aims to improve the health and well-being of its customers by providing accessible therapeutic options and effective alternatives to prescription medicines.
Perrigo Company shares surged after issuing financial targets for 2025 & 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. 'Three-S' plan will enhance cash flow & shareholder return. Q4 results below estimates.
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive healthcare access now.
Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending.
